- The role of direct oral anticoagulants in venous thromboembolic disease in gynecologic cancer
-
Park JY
- KMID: 2465198
- J Gynecol Oncol.
- 2020 Jan;31(1):e40.
- doi: 10.3802/jgo.2020.31.e40
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Non-Vitamin K Antagonist Oral Anticoagulants in Medical Conditions at High Risk of Thromboembolism beyond Atrial Fibrillation
-
Hong KS
- KMID: 2464644
- J Stroke.
- 2019 Sep;21(3):259-275.
- doi: 10.5853/jos.2019.01970
Non-Vitamin K antagonist oral anticoagulants (NOACs) have been extensively investigated in medical conditions at high risk of venous or arterial thrombosis other than atrial fibrillation (AF), including hip or knee... -
- CITED
-
- Close
- SHARE
-
- Close
- The Role of Novel Oral Anticoagulants and Antiplatelet Therapy after Percutaneous Coronary Intervention: Individualizing Therapy to Optimize Outcomes
-
Shlofmitz , Shlofmitz , Lee MS
- KMID: 2456861
- Korean Circ J.
- 2019 Aug;49(8):645-656.
- doi: 10.4070/kcj.2019.0185
The number of patients undergoing percutaneous coronary intervention (PCI) who mandate additional oral anticoagulant therapy has been increasing. Dual antiplatelet therapy (DAPT) is associated with reduced ischemic events including stent... -
- CITED
-
- Close
- SHARE
-
- Close
- New Oral Anticoagulants versus Warfarin for Cerebral Venous Thrombosis: A Multi-Center, Observational Study
-
Wasay M, Khan M, Rajput HM, Farooq S, Memon MI, AlRukn SA, Malik A, Abd-Allah , Shoaib RF, Shahid R, Nishat S, Awan S
- KMID: 2449900
- J Stroke.
- 2019 May;21(2):220-223.
- doi: 10.5853/jos.2019.00150
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Anticoagulants in Older Patients with Nonvalvular Atrial Fibrillation after Intracranial Hemorrhage
-
Perreault , Côté R, White-Guay B, Dorais M, Oussaïd E, Schnitzer
- KMID: 2449897
- J Stroke.
- 2019 May;21(2):195-206.
- doi: 10.5853/jos.2018.02243
BACKGROUND AND PURPOSE: Patients with nonvalvular atrial fibrillation (NVAF) who survive an intracranial hemorrhage (ICH) have an increased risk of ischemic stroke and systemic embolism (IS/SE). We investigated whether starting... -
- CITED
-
- Close
- SHARE
-
- Close
- Label Adherence for Non-Vitamin K Antagonist Oral Anticoagulants in a Prospective Cohort of Asian Patients with Atrial Fibrillation
-
Lee SR, Lee YS, Park JS, Cha MJ, Kim TH, Park J, Park JK, Lee JM, Kang KW, Shim J, Uhm JS, Kim J, Kim C, Kim JB, Park HW, Joung B, Choi EK
- KMID: 2441305
- Yonsei Med J.
- 2019 Mar;60(3):277-284.
- doi: 10.3349/ymj.2019.60.3.277
PURPOSE: Label adherence for non-vitamin K antagonist oral anticoagulants (NOACs) has not been well evaluated in Asian patients with non-valvular atrial fibrillation (AF). The present study aimed to assess label... -
- CITED
-
- Close
- SHARE
-
- Close
- 2018 Korean Heart Rhythm Society Guidelines for Non-Vitamin K Antagonist Oral Anticoagulants
-
Park YM, Park HW, Lee JM, Park JK, Lee KH, Kim JB, Lee YS, Joung B
- KMID: 2438028
- Korean J Med.
- 2019 Feb;94(1):57-82.
- doi: 10.3904/kjm.2019.94.1.57
Non-vitamin K antagonist oral anticoagulants (NOACs) are an alternative to vitamin K antagonists (VKAs) and have emerged as the treatment of choice in Korea. However, several questions remain regarding the... -
- CITED
-
- Close
- SHARE
-
- Close
- The 2018 Korean Heart Rhythm Society Practical Guidelines on the use of Non-Vitamin K-Antagonist Oral Anticoagulants: Bleeding Control and Perioperative Management
-
Lee JH, Lim HE, Lim WH, Ahn J, Cha MJ, Park J, Lee KH, Park HC, Choi EK, Joung B
- KMID: 2438027
- Korean J Med.
- 2019 Feb;94(1):40-56.
- doi: 10.3904/kjm.2019.94.1.40
Although non-vitamin K-antagonist oral anticoagulants (NOACs) reduce major bleeding events in patients with atrial fibrillation more effectively than does warfarin, a significant bleeding risk remains. Patients exhibiting current bleeding and... -
- CITED
-
- Close
- SHARE
-
- Close
- 2018 KHRS Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Korean Patients with Atrial Fibrillation: How to Initiate and Organize the Follow-up
-
Park JK, Kim J, Baek YS, Lee SR, Hwang YM, Kim TH, Lee DI, Lee KH, Shim J, Joung B
- KMID: 2438026
- Korean J Med.
- 2019 Feb;94(1):17-39.
- doi: 10.3904/kjm.2019.94.1.17
Non-vitamin K antagonist oral anticoagulants (NOACs) are alternatives to vitamin K antagonists to prevent stroke in patients with non-valvular atrial fibrillation (AF) and have emerged as the preferred choice. The... -
- CITED
-
- Close
- SHARE
-
- Close
- Current Management of Cancer-associated Venous Thromboembolism: Focus on Direct Oral Anticoagulants
-
Kim SA, Yhim HY, Bang SM
- KMID: 2437951
- J Korean Med Sci.
- 2019 Feb;34(6):e52.
- doi: 10.3346/jkms.2019.34.e52
Cancer-associated venous thromboembolism (CAT) is a common complication associated with high morbidity and mortality. In accordance with major clinical trials comparing low-molecular-weight heparin (LMWH) with a vitamin K antagonist (VKA),... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk Factors of Gastrointestinal Bleeding in Patients Receiving New Oral Anticoagulants
-
Lee JY
- KMID: 2428008
- Korean J Helicobacter Up Gastrointest Res.
- 2018 Dec;18(4):219-224.
- doi: 10.7704/kjhugr.2018.18.4.219
New oral anticoagulants (NOACs) are now widely used for the prevention and treatment of venous thrombosis, and for the prevention of stroke and systemic embolism in patients with atrial fibrillation.... -
- CITED
-
- Close
- SHARE
-
- Close
- Non-Vitamin K Oral Anticoagulants Associated Bleeding and Its Antidotes
-
Steiner T, Köhrmann , Schellinger PD, Tsivgoulis G
- KMID: 2428765
- J Stroke.
- 2018 Sep;20(3):292-301.
- doi: 10.5853/jos.2018.02250
Oral anticoagulant-associated intracerebral hemorrhage (OAC-ICH) accounts for nearly 20% of all ICH. The number of patients with an indication for oral anticoagulant therapy (OAT) increases with increasing age. OAT became... -
- CITED
-
- Close
- SHARE
-
- Close
- Oral Anticoagulants for Atrial Fibrillation Patients with Active Cancer
-
Kim DY, Lim HE
- KMID: 2414913
- Korean Circ J.
- 2018 May;48(5):433-434.
- doi: 10.4070/kcj.2018.0081
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Newly Diagnosed Cancer
-
Kim K, Lee YJ, Kim TH, Uhm JS, Pak HN, Lee MH, Joung B
- KMID: 2414909
- Korean Circ J.
- 2018 May;48(5):406-417.
- doi: 10.4070/kcj.2017.0328
BACKGROUND AND OBJECTIVES: There are limited data on the use of non-vitamin K antagonist oral anticoagulants (NOACs) in atrial fibrillation (AF) patients with cancer. We aimed to assess the efficacy... -
- CITED
-
- Close
- SHARE
-
- Close
- 2018 KHRS Expert Consensus Recommendation for Oral Anticoagulants Choice and Appropriate Doses: Specific Situation and High Risk Patients
-
Lee KH, Joung B, Lee SR, Hwang YM, Park J, Baek YS, Park YM, Park JK, Park HC, Park HW, Lee YS, Choi KJ
- KMID: 2435176
- Korean J Med.
- 2018 Apr;93(2):110-132.
- doi: 10.3904/kjm.2018.93.2.110
Oral anticoagulants (OAC) are necessary to prevent thromboembolism in patients with atrial fibrillation (AF). OACs used in Korea are composed of warfarin and non-vitamin K antagonist OAC. Risk stratification and... -
- CITED
-
- Close
- SHARE
-
- Close
- Adaptation of New Oral Anticoagulants for Warfarin Anticoagulated Patient with Traumatic Ongoing Hemorrhage
-
Ye JB, Sul YH, Lee JY, Go SJ, Choi JH
- KMID: 2434954
- J Acute Care Surg.
- 2018 Apr;8(1):33-37.
- doi: 10.17479/jacs.2018.8.1.33
The traditional drug for anticoagulation in those with a high risk of thrombosis is a vitamin K antagonist, such as warfarin. On the other hand, this drug has several limitations... -
- CITED
-
- Close
- SHARE
-
- Close
- Real-world Data and Recommended Dosage of Non-vitamin K Oral Anticoagulants for Korean Patients
-
Joung B
- KMID: 2396475
- Korean Circ J.
- 2017 Nov;47(6):833-841.
- doi: 10.4070/kcj.2017.0158
Regulatory approvals of non-vitamin K antagonist oral anticoagulants (NOACs) have been based on large randomized phase III trials evaluating dabigatran, rivaroxaban, apixaban, or edoxaban relative to warfarin for atrial fibrillation... -
- CITED
-
- Close
- SHARE
-
- Close
- Delayed Sciatic Nerve Palsy due to Hematoma Related with Anticoagulants Prophylaxis in the Femur Intramedullary Nailing: A Case Report
-
Kim YM, Joo YB, Song SH
- KMID: 2424132
- J Korean Fract Soc.
- 2017 Oct;30(4):198-202.
- doi: 10.12671/jkfs.2017.30.4.198
Femur intramedullary nailing can be one of the most predictable procedures in orthopedic traumatology. The advantage of this method is that the fracture site does not have to be widely... -
- CITED
-
- Close
- SHARE
-
- Close
- New Anticoagulants for the Prevention and Treatment of Venous Thromboembolism
-
Kim JH, Lim KM, Gwak HS
- KMID: 2389377
- Biomol Ther.
- 2017 Sep;25(5):461-470.
- doi: 10.4062/biomolther.2016.271
Anticoagulant drugs, like vitamin K antagonists and heparin, have been the mainstay for the treatment and prevention of venous thromboembolic disease for many years. Although effective if appropriately used, traditional... -
- CITED
-
- Close
- SHARE
-
- Close
- Delayed bleeding after implant surgery in patients taking novel oral anticoagulants: a case report
-
Kim C, Dam C, Jeong J, Kwak EJ, Park W
- KMID: 2384477
- J Dent Anesth Pain Med.
- 2017 Jun;17(2):143-147.
- doi: 10.17245/jdapm.2017.17.2.143
The use of novel oral anticoagulants (NOACs) has increased in recent times in an effort to overcome the shortcomings of warfarin. They are being used primarily for the prevention of... -
- CITED
-
- Close
- SHARE
-
- Close
